Arrowstreet Capital
ISEE

Arrowstreet Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Arrowstreet Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-102,641
Closed -$523K – 2587
2020
Q2 		$523K Buy
102,641
+41,058
+67% +$171K ﹤0.01% 1948
2020
Q1 		$212K Buy
+61,583
New +$360K ﹤0.01% 1720
2016
Q4 		– Sell
-5,600
Closed -$258K – 2643
2016
Q3 		$258K Buy
+5,600
New +$316K ﹤0.01% 1381
2015
Q3 		– Sell
-18,800
Closed -$979K – 1537
2015
Q2 		$979K Buy
+18,800
New +$935K 0.01% 828

Other funds holding ISEE

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Arrowstreet Capital's ISEE Position: Q3 2020 in Review

Arrowstreet Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2020, closing a stake of 102,641 shares — an estimated $523K sold.

Arrowstreet Capital first reported a position in ISEE in Q2 2015 and held it in 4 quarters. The position peaked at $979K in Q2 2015. 100 funds tracked by Wall St. Rank hold ISEE as of Q3 2020.

  • Arrowstreet Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 102,641 IVERIC bio, Inc. Common Stock shares in Q3 2020, an estimated $523K.
  • Arrowstreet Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 4 quarters.
  • Arrowstreet Capital's IVERIC bio, Inc. Common Stock position peaked at $979K in Q2 2015.
  • 100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.